3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
44
Recurrence
9
Sarcoma, Kaposi
2
Neoplasms, Plasma Cell
2
Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Burkitt Lymphoma
2
Acquired Immunodeficiency Syndrome
2
Plasmacytoma
1
Plasmablastic Lymphoma
1
Multi-centric Castleman's Disease
1
Malignant Plasma Cell Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Epstein-Barr Virus Infections
1
Interventions
AZD 6244
7
trametinib
4
mirdametinib
2
fludarabine
2
Inhalation
2
Acetylcysteine
2
thymoglobulin
1
talimogene laherparepvec
1
omipalisib
1
lorlatinib
1
fludarabine phosphate
1
encorafenib
1
dabrafenib
1
binimetinib
1
abemaciclib
1
Vincristine
1
Specimen Handling
1
Sirolimus
1
Rituximab
1
Radiation
1
N-monoacetylcystine
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Levetiracetam
1
Lasers, Solid-State
1
Lasers
1
Injections
1
Deoxycholic Acid
1
Cytarabine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurofibromatosis 1
×
pomalidomide
×
90 days
×
Clear all
No trials found.